| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2017* | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (vol 9, pg 1275, 2021) RA Evans, H McAuley, EM Harrison LANCET RESPIRATORY MEDICINE 10 (1), E9-E9, 2022 | 515* | 2022 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 452* | 2021 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 304 | 2022 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 302 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 236 | 2022 |
| COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD H McAuley, K Hadley, O Elneima, CE Brightling, RA Evans, MC Steiner, ... ERJ Open Research 7 (1), 2021 | 77 | 2021 |
| Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post–COVID-19 study I Stewart, J Jacob, PM George, PL Molyneaux, JC Porter, RJ Allen, ... American journal of respiratory and critical care medicine 207 (6), 693-703, 2023 | 67 | 2023 |
| Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation SJ Singh, MM Baldwin, E Daynes, RA Evans, NJ Greening, RG Jenkins, ... The Lancet Respiratory Medicine 11 (8), 709-725, 2023 | 43 | 2023 |
| Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization M Taquet, Z Skorniewska, A Hampshire, JD Chalmers, LP Ho, A Horsley, ... Nature medicine 29 (10), 2498-2508, 2023 | 40 | 2023 |
| Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19 L Houchen-Wolloff, K Poinasamy, K Holmes, M Tarpey, C Hastie, ... Thorax 77 (7), 717-720, 2022 | 23 | 2022 |
| Longitudinal changes to quadriceps thickness demonstrate acute sarcopenia following admission to hospital for an exacerbation of chronic respiratory disease HJC McAuley, TC Harvey-Dunstan, M Craner, M Richardson, SJ Singh, ... Thorax 76 (7), 726-728, 2021 | 21 | 2021 |
| The different phenotypes of COPD A Yousuf, H McAuley, O Elneima, CE Brightling British Medical Bulletin 137 (1), 82-97, 2021 | 16 | 2021 |
| Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study B Raman, C McCracken, MP Cassar, AJ Moss, L Finnigan, AHA Samat, ... The Lancet Respiratory Medicine 11 (11), 1003-1019, 2023 | 15 | 2023 |
| Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19 L Daines, B Zheng, O Elneima, E Harrison, NI Lone, JR Hurst, JS Brown, ... ERJ open research 9 (1), 2023 | 15 | 2023 |
| The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the … E Daynes, M Baldwin, NJ Greening, T Yates, NC Bishop, G Mills, ... Trials 24 (1), 61, 2023 | 14 | 2023 |
| Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study C Jackson, ID Stewart, T Plekhanova, PS Cunningham, AL Hazel, ... The Lancet Respiratory Medicine 11 (8), 673-684, 2023 | 13 | 2023 |
| Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls B Zheng, G Vivaldi, L Daines, OC Leavy, M Richardson, O Elneima, ... The Lancet Regional Health–Europe 29, 2023 | 12 | 2023 |
| Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial HR Keir, MB Long, H Abo-Leyah, YH Giam, T Vadiveloo, T Pembridge, ... The Lancet Respiratory Medicine 10 (12), 1119-1128, 2022 | 11 | 2022 |
| Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study HJC McAuley, RA Evans, CE Bolton, CE Brightling, JD Chalmers, ... EClinicalMedicine 57, 2023 | 10 | 2023 |
